Viral modulation of NK cell immunity

[1]  L. Lanier,et al.  The Cytomegalovirus m155 Gene Product Subverts Natural Killer Cell Antiviral Protection by Disruption of H60–NKG2D Interactions , 2004, The Journal of experimental medicine.

[2]  Salim I. Khakoo,et al.  HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection , 2004, Science.

[3]  E. Mocarski.  Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system , 2004, Cellular microbiology.

[4]  S. Akira,et al.  TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. , 2004, Immunity.

[5]  G. Abenes,et al.  Murine Cytomegalovirus with a Transposon Insertional Mutation at Open Reading Frame m155 Is Deficient in Growth and Virulence in Mice , 2004, Journal of Virology.

[6]  G. Karupiah,et al.  Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Jonjić,et al.  Escape of mutant double-stranded DNA virus from innate immune control. , 2004, Immunity.

[8]  S. Akira,et al.  Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. , 2004, Blood.

[9]  M. Ressing,et al.  Human Cytomegalovirus-Encoded US2 Differentially Affects Surface Expression of MHC Class I Locus Products and Targets Membrane-Bound, but Not Soluble HLA-G1 for Degradation 1 , 2003, The Journal of Immunology.

[10]  M. Degli-Esposti,et al.  Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Mikael Eriksson,et al.  Effects of Human Cytomegalovirus Infection on Ligands for the Activating NKG2D Receptor of NK Cells: Up-Regulation of UL16-Binding Protein (ULBP)1 and ULBP2 Is Counteracted by the Viral UL16 Protein1 , 2003, The Journal of Immunology.

[12]  C. Sutherland,et al.  Human Cytomegalovirus Glycoprotein UL16 Causes Intracellular Sequestration of NKG2D Ligands, Protecting Against Natural Killer Cell Cytotoxicity , 2003, The Journal of experimental medicine.

[13]  C. Sutherland,et al.  ULBP4 is a novel ligand for human NKG2D. , 2003, Biochemical and biophysical research communications.

[14]  L. Lanier,et al.  NKG2D-mediated Natural Killer Cell Protection Against Cytomegalovirus Is Impaired by Viral gp40 Modulation of Retinoic Acid Early Inducible 1 Gene Molecules , 2003, The Journal of experimental medicine.

[15]  S. Riddell,et al.  Intracellular Retention of the MHC Class I-Related Chain B Ligand of NKG2D by the Human Cytomegalovirus UL16 Glycoprotein1 , 2003, The Journal of Immunology.

[16]  S. Bahram,et al.  In vivo immunogenetics: from MIC to RAET1 loci , 2003, Immunogenetics.

[17]  Acknowledgements , 2003, Psychoneuroendocrinology.

[18]  P. Gros,et al.  Transgenic Expression of the Activating Natural Killer Receptor Ly49H Confers Resistance to Cytomegalovirus in Genetically Susceptible Mice , 2003, The Journal of experimental medicine.

[19]  A. Diefenbach,et al.  A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity , 2003, European journal of immunology.

[20]  H. Rammensee,et al.  Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein , 2003, European journal of immunology.

[21]  M. Reddehase.  Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance , 2002, Nature Reviews Immunology.

[22]  D. Fremont,et al.  Cutting Edge: Murine UL16-Binding Protein-Like Transcript 1: A Newly Described Transcript Encoding a High-Affinity Ligand for Murine NKG2D1 , 2002, The Journal of Immunology.

[23]  U. Koszinowski,et al.  Major Histocompatibility Complex Class I Allele-specific Cooperative and Competitive Interactions between Immune Evasion Proteins of Cytomegalovirus , 2002, The Journal of experimental medicine.

[24]  M. Mach,et al.  NK Cell Activity During Human Cytomegalovirus Infection Is Dominated by US2–11-Mediated HLA Class I Down-Regulation1 , 2002, The Journal of Immunology.

[25]  Keith Hoots,et al.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.

[26]  A. Diefenbach,et al.  The role of the NKG2D immunoreceptor in immune cell activation and natural killing. , 2002, Immunity.

[27]  D. Fremont,et al.  Recognition of a virus-encoded ligand by a natural killer cell activation receptor , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  H. Ploegh,et al.  Kaposi's Sarcoma-Associated Herpesvirus K3 Utilizes the Ubiquitin-Proteasome System in Routing Class I Major Histocompatibility Complexes to Late Endocytic Compartments , 2002, Journal of Virology.

[29]  P. Tomasec,et al.  UL40-mediated NK evasion during productive infection with human cytomegalovirus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Busch,et al.  MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo , 2002, Nature Immunology.

[31]  L. Lanier,et al.  Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors , 2002, Science.

[32]  A. Bartolazzi,et al.  Pivotal Role of KARAP/DAP12 Adaptor Molecule in the Natural Killer Cell–mediated Resistance to Murine Cytomegalovirus Infection , 2002, The Journal of experimental medicine.

[33]  T. Shenk,et al.  Murine Cytomegalovirus m02 Gene Family Protects against Natural Killer Cell-Mediated Immune Surveillance , 2002, Journal of Virology.

[34]  C. Tseng,et al.  Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions , 2002, The Journal of experimental medicine.

[35]  S. Nuti,et al.  Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein , 2002, The Journal of experimental medicine.

[36]  U. Koszinowski,et al.  The Multiple Immune-Evasion Genes of Murine Cytomegalovirus Are Not Redundant , 2001, The Journal of experimental medicine.

[37]  E. Carbone,et al.  Synergistic effect of IFN‐γ and human cytomegalovirus protein UL40 in the HLA‐E‐dependent protection from NK cell‐mediated cytotoxicity , 2001, European journal of immunology.

[38]  U. Koszinowski,et al.  The Murine Cytomegalovirus Immune Evasion Protein m4/gp34 Forms Biochemically Distinct Complexes with Class I MHC at the Cell Surface and in a Pre-Golgi Compartment1 , 2001, The Journal of Immunology.

[39]  Adelheid Cerwenka,et al.  Natural killer cells, viruses and cancer , 2001, Nature Reviews Immunology.

[40]  Raymond M. Welsh,et al.  Murine Cytomegalovirus Is Regulated by a Discrete Subset of Natural Killer Cells Reactive with Monoclonal Antibody to Ly49h , 2001, The Journal of experimental medicine.

[41]  S. Anderson,et al.  The ever‐expanding Ly49 gene family: repertoire and signaling , 2001, Immunological reviews.

[42]  D. Ganem,et al.  A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. , 2001, The Journal of clinical investigation.

[43]  A. Scalzo,et al.  Cutting Edge: A NK Complex-Linked Locus Governs Acute Versus Latent Herpes Simplex Virus Infection of Neurons1 , 2001, The Journal of Immunology.

[44]  Jonathan W. Heusel,et al.  Vital Involvement of a Natural Killer Cell Activation Receptor in Resistance to Viral Infection , 2001, Science.

[45]  Seung-Hwan Lee,et al.  Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily , 2001, Nature Genetics.

[46]  E. Rosenberg,et al.  Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  T. Kuwana,et al.  Granzyme B-mediated Apoptosis Proceeds Predominantly through a Bcl-2-inhibitable Mitochondrial Pathway* 210 , 2001, The Journal of Biological Chemistry.

[48]  S. Riddell,et al.  Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells , 2001, Nature Immunology.

[49]  R. Armitage,et al.  ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. , 2001, Immunity.

[50]  C. K. Tseng,et al.  Crosslinking CD81 Results in Activation of TCRγδ T Cells , 2001 .

[51]  S. Nuti,et al.  Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co‐stimulatory signal for human T cells , 2001, European journal of immunology.

[52]  J. Trapani,et al.  Initiation of Apoptosis by Granzyme B Requires Direct Cleavage of Bid, but Not Direct Granzyme B–Mediated Caspase Activation , 2000, The Journal of experimental medicine.

[53]  B. Walker,et al.  Distinct Trafficking Pathways Mediate Nef-Induced and Clathrin-Dependent Major Histocompatibility Complex Class I Down-Regulation , 2000, Journal of Virology.

[54]  R. Johnson,et al.  Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. , 2000, Immunity.

[55]  N. Shastri,et al.  Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages , 2000, Nature Immunology.

[56]  D. Ganem,et al.  Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[57]  T. Mcclanahan,et al.  Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. , 2000, Immunity.

[58]  J. Ellwart,et al.  Cutting Edge: The Human Cytomegalovirus UL40 Gene Product Contains a Ligand for HLA-E and Prevents NK Cell-Mediated Lysis1 , 2000, The Journal of Immunology.

[59]  P. A. Peterson,et al.  Human Cytomegalovirus Immediate Early Glycoprotein US3 Retains MHC Class I Molecules by Transient Association , 2000, Traffic.

[60]  L. Morrison,et al.  A Poxvirus Protein That Binds to and Inactivates IL-18, and Inhibits NK Cell Response1 , 2000, The Journal of Immunology.

[61]  E. Kremmer,et al.  The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules , 2000, The EMBO journal.

[62]  G. Geginat,et al.  The Putative Natural Killer Decoy Early Genem04 (gp34) of Murine Cytomegalovirus Encodes an Antigenic Peptide Recognized by Protective Antiviral CD8 T Cells , 2000, Journal of Virology.

[63]  A. McMichael,et al.  Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. , 2000, Science.

[64]  K. Früh,et al.  A role for MHC class I down‐regulation in NK cell lysis of herpes virus‐infected cells , 2000, European journal of immunology.

[65]  P. Ross-Macdonald,et al.  Mutagenesis of murine cytomegalovirus using a Tn3-based transposon. , 2000, Virology.

[66]  P. Bjorkman,et al.  The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. , 1999, Immunity.

[67]  B. Moss,et al.  IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[68]  M. Smyth,et al.  M144, a Murine Cytomegalovirus (Mcmv)-Encoded Major Histocompatibility Complex Class I Homologue, Confers Tumor Resistance to Natural Killer Cell–Mediated Rejection , 1999, The Journal of experimental medicine.

[69]  A Steinle,et al.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.

[70]  D. Baltimore,et al.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. , 1999, Immunity.

[71]  U. Koszinowski,et al.  A cytomegalovirus glycoprotein re‐routes MHC class I complexes to lysosomes for degradation , 1999, The EMBO journal.

[72]  M. Houghton,et al.  Binding of hepatitis C virus to CD81. , 1998, Science.

[73]  Kathleen M. Smith,et al.  Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. , 1998, Journal of immunology.

[74]  P. Bjorkman,et al.  Modulation of Natural Killer Cell Cytotoxicity in Human Cytomegalovirus Infection: The Role of Endogenous Class I Major Histocompatibility Complex and a Viral Class I Homolog , 1998, The Journal of experimental medicine.

[75]  S. Le Gall,et al.  Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. , 1998, Immunity.

[76]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[77]  M. Kubin,et al.  A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. , 1997, Immunity.

[78]  A. McMichael,et al.  The human major histocompatibility complex class Ib molecule HLA‐E binds signal sequence‐derived peptides with primary anchor residues at positions 2 and 9 , 1997, European journal of immunology.

[79]  U. Koszinowski,et al.  A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. , 1997, Immunity.

[80]  P. A. Peterson,et al.  The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. , 1997, Immunity.

[81]  O. Mandelboim,et al.  The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells , 1997, Nature.

[82]  H. Vally,et al.  Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo , 1997, Nature.

[83]  H. Ploegh,et al.  A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface , 1997, The EMBO journal.

[84]  R. Welsh,et al.  Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells , 1997, Journal of virology.

[85]  T. Rapoport,et al.  Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction , 1996, Nature.

[86]  H. Ploegh,et al.  Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[87]  E. Podack,et al.  Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. , 1996, Journal of immunology.

[88]  M. Bogyo,et al.  The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the Cytosol , 1996, Cell.

[89]  F. Lemonnier,et al.  Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein , 1996, Nature Medicine.

[90]  William Arbuthnot Sir Lane,et al.  The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. , 1995, Immunity.

[91]  D. Brownstein,et al.  Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype , 1995, Journal of virology.

[92]  P. A. Peterson,et al.  A viral inhibitor of peptide transporters for antigen presentation , 1995, Nature.

[93]  L. Lanier,et al.  Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. , 1992, Journal of immunology.

[94]  A. Scalzo,et al.  Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen , 1990, The Journal of experimental medicine.

[95]  L. Lanier,et al.  Comparative studies of human FcRIII-positive and negative natural killer cells. , 1989, Journal of immunology.

[96]  J L Sullivan,et al.  Severe herpesvirus infections in an adolescent without natural killer cells. , 1989, The New England journal of medicine.

[97]  J. A. Payne,et al.  Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[98]  R. Demars,et al.  Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell‐mediated lysis is inversely correlated with HLA class I antigen expression , 1989, European journal of immunology.

[99]  S. Beck,et al.  Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens , 1988, Nature.

[100]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[101]  H. Ljunggren,et al.  Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism , 1985, The Journal of experimental medicine.

[102]  R. Buller,et al.  Genetic determinants of resistance to ectromelia (mousepox) virus-induced mortality , 1985, Journal of virology.

[103]  R. Welsh,et al.  Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo , 1985, The Journal of experimental medicine.

[104]  Lewis L Lanier,et al.  NK cell recognition. , 2005, Annual review of immunology.

[105]  D. Brownstein,et al.  Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus , 2005, Archives of Virology.

[106]  Peter Parham,et al.  KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. , 2002, Annual review of immunology.

[107]  L. Lanier.  On guard—activating NK cell receptors , 2001, Nature Immunology.

[108]  H. Ploegh,et al.  Viral subversion of the immune system. , 2000, Annual review of immunology.

[109]  A. McMichael,et al.  Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E. , 1999, Current topics in microbiology and immunology.

[110]  L. Lanier.  NK cell receptors. , 1998, Annual review of immunology.

[111]  U. Koszinowski,et al.  A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. , 1997, Immunity.